| NCT Number | NCT07457944 |
| Lead Sponsor | Ruijin Hospital
Collaborators: Peking University First Hospital, Guangdong Provincial Dermatology Hospital, Chinese Academy of Medical Sciences, West China Hospital, Second Xiangya Hospital of Central South University |
| Conditions | Pemphigus Disease, Rituximab (RTx) |
| Enrollment | 275 participants |
| Start Date | 2019-01-01 |
| Primary Completion | 2023-01-01 (estimated) |
| Study Completion | 2026-01-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-09 |